Skip to main content
Erschienen in: Inflammation 6/2017

31.07.2017 | ORIGINAL ARTICLE

Roburic Acid Suppresses NO and IL-6 Production via Targeting NF-κB and MAPK Pathway in RAW264.7 Cells

verfasst von: Yufen Chen, Ning Ji, Shunli Pan, Zhe Zhang, Ran Wang, Yuling Qiu, Meihua Jin, Dexin Kong

Erschienen in: Inflammation | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

In the present study, we investigated the anti-inflammatory effect of roburic acid on production of nitric oxide (NO) and interlukin-6 (IL-6) in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells. We found that roburic acid reduced production of NO and IL-6, and the expression of inducible nitric oxide synthases (iNOS). Meanwhile, phosphorylation of inhibitor of κBα (IκBα) and IκB kinase α/β (IKKα/β), as well as translocation of nuclear factor-κB (NF-κB) to the nucleus, was suppressed by roburic acid treatment. In addition, phosphorylation of mitogen-activated protein kinase (MAPKs) including p38 and c-Jun-NH2-terminal kinase (JNK) was inhibited. Roburic acid exhibited inhibitory activities on production of NO and IL-6 via blocking IKK/IκB/NF-κB and MAPKs pathway, suggesting the potential application as a drug candidate for therapy of inflammatory diseases.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Decano, J.L., P.C. Mattson, and M. Aikawa. 2016. Macrophages in Vascular Inflammation: Origins and Functions. Current Atherosclerosis Reports 18 (6): 34.CrossRefPubMed Decano, J.L., P.C. Mattson, and M. Aikawa. 2016. Macrophages in Vascular Inflammation: Origins and Functions. Current Atherosclerosis Reports 18 (6): 34.CrossRefPubMed
3.
Zurück zum Zitat Gordon, S. 2007. The macrophage: past, present and future. European Journal of Immunology S9–17 Gordon, S. 2007. The macrophage: past, present and future. European Journal of Immunology S9–17
4.
Zurück zum Zitat Guzik, T.J., R. Korbut, and T. Adamek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology 54 (4): 469–487.PubMed Guzik, T.J., R. Korbut, and T. Adamek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology 54 (4): 469–487.PubMed
5.
6.
Zurück zum Zitat Yao, X., J. Huang, H. Zhong, N. Shen, R. Faggioni, M. Fung, and Y. Yao. 2014. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics 141 (2): 125–139.CrossRef Yao, X., J. Huang, H. Zhong, N. Shen, R. Faggioni, M. Fung, and Y. Yao. 2014. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics 141 (2): 125–139.CrossRef
7.
Zurück zum Zitat Gabay, C. 2006. Interleukin-6 and chronic inflammation. Arthritis Research & Therapy 8 (Suppl 2): S3.CrossRef Gabay, C. 2006. Interleukin-6 and chronic inflammation. Arthritis Research & Therapy 8 (Suppl 2): S3.CrossRef
8.
Zurück zum Zitat Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. International Immunology 17 (1): 1–14.CrossRefPubMed Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. International Immunology 17 (1): 1–14.CrossRefPubMed
9.
Zurück zum Zitat Matsuno, R., Y. Aramaki, H. Arima, Y. Adachi, N. Ohno, T. Yadomae, and S. Tsuchiya. 1998. Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS. Biochemical and Biophysical Research Communications 244 (1): 115–119.CrossRefPubMed Matsuno, R., Y. Aramaki, H. Arima, Y. Adachi, N. Ohno, T. Yadomae, and S. Tsuchiya. 1998. Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS. Biochemical and Biophysical Research Communications 244 (1): 115–119.CrossRefPubMed
10.
Zurück zum Zitat Chen, X., S.A. Tang, E. Lee, Y. Qiu, R. Wang, H.Q. Duan, S. Dan, M. Jin, and D. Kong. 2015. IVSE, isolated from Inula japonica,suppresses LPS-induced NO production via NF-kappaB and MAPK inactivation in RAW264.7 cells. Life Sciences 124: 8–15.CrossRefPubMed Chen, X., S.A. Tang, E. Lee, Y. Qiu, R. Wang, H.Q. Duan, S. Dan, M. Jin, and D. Kong. 2015. IVSE, isolated from Inula japonica,suppresses LPS-induced NO production via NF-kappaB and MAPK inactivation in RAW264.7 cells. Life Sciences 124: 8–15.CrossRefPubMed
11.
Zurück zum Zitat Park, H.H., M.J. Kim, Y. Li, Y.N. Park, J. Lee, Y.J. Lee, S.G. Kim, et al. 2013. Britanin suppresses LPS-induced nitric oxide, PGE2 and cytokine production via NF-kappaB and MAPK inactivation in RAW 264.7 cells. International Immunopharmacology 15 (2): 296–302.CrossRefPubMed Park, H.H., M.J. Kim, Y. Li, Y.N. Park, J. Lee, Y.J. Lee, S.G. Kim, et al. 2013. Britanin suppresses LPS-induced nitric oxide, PGE2 and cytokine production via NF-kappaB and MAPK inactivation in RAW 264.7 cells. International Immunopharmacology 15 (2): 296–302.CrossRefPubMed
12.
Zurück zum Zitat Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annual Review of Immunology 18: 621–663.CrossRefPubMed Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annual Review of Immunology 18: 621–663.CrossRefPubMed
13.
Zurück zum Zitat Li, X., S. Jiang, and R.I. Tapping. 2010. Toll-like receptor signaling in cell proliferation and survival. Cytokine 49 (1): 1–9.CrossRefPubMed Li, X., S. Jiang, and R.I. Tapping. 2010. Toll-like receptor signaling in cell proliferation and survival. Cytokine 49 (1): 1–9.CrossRefPubMed
14.
Zurück zum Zitat Wang, X., S.A. Tang, R. Wang, Y. Qiu, M. Jin, and D. Kong. 2015. Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells. Inflammation 38 (3): 941–948.CrossRefPubMed Wang, X., S.A. Tang, R. Wang, Y. Qiu, M. Jin, and D. Kong. 2015. Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells. Inflammation 38 (3): 941–948.CrossRefPubMed
15.
Zurück zum Zitat Hommes, D.W., M.P. Peppelenbosch, and S.J. van Deventer. 2003. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52 (1): 144–151.CrossRefPubMedPubMedCentral Hommes, D.W., M.P. Peppelenbosch, and S.J. van Deventer. 2003. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52 (1): 144–151.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Wu, Li-Hong, S.W. Annie Bligh, Christine J. Leon, Xing-Shang Li, Zheng-Tao Wang, Christopher J. Branford-White, and Monique S.J. Simmonds. 2012. Chemotaxonomically significant roburic acid from Section Cruciata of Gentiana. Biochemical Systematics and Ecology 43: 152–155.CrossRef Wu, Li-Hong, S.W. Annie Bligh, Christine J. Leon, Xing-Shang Li, Zheng-Tao Wang, Christopher J. Branford-White, and Monique S.J. Simmonds. 2012. Chemotaxonomically significant roburic acid from Section Cruciata of Gentiana. Biochemical Systematics and Ecology 43: 152–155.CrossRef
17.
Zurück zum Zitat Verhoff, M., S. Seitz, M. Paul, S.M. Noha, J. Jauch, D. Schuster, and O. Werz. 2014. Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1. Journal of Natural Products 77 (6): 1445–1451.CrossRefPubMedPubMedCentral Verhoff, M., S. Seitz, M. Paul, S.M. Noha, J. Jauch, D. Schuster, and O. Werz. 2014. Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1. Journal of Natural Products 77 (6): 1445–1451.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Jin, M., S.J. Suh, J.H. Yang, Y. Lu, S.J. Kim, S. Kwon, T.H. Jo, et al. 2010. Anti-inflammatory activity of bark of Dioscorea batatas DECNE through the inhibition of iNOS and COX-2 expressions in RAW264.7 cells via NF-kappaB and ERK1/2 inactivation. Food and Chemical Toxicology 48 (11): 3073–3079.CrossRefPubMed Jin, M., S.J. Suh, J.H. Yang, Y. Lu, S.J. Kim, S. Kwon, T.H. Jo, et al. 2010. Anti-inflammatory activity of bark of Dioscorea batatas DECNE through the inhibition of iNOS and COX-2 expressions in RAW264.7 cells via NF-kappaB and ERK1/2 inactivation. Food and Chemical Toxicology 48 (11): 3073–3079.CrossRefPubMed
19.
Zurück zum Zitat Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl): S81–S96.CrossRefPubMed Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl): S81–S96.CrossRefPubMed
20.
Zurück zum Zitat Kim, E.K., and E.J. Choi. 2015. Compromised MAPK signaling in human diseases: an update. Archives of Toxicology 89 (6): 867–882.CrossRefPubMed Kim, E.K., and E.J. Choi. 2015. Compromised MAPK signaling in human diseases: an update. Archives of Toxicology 89 (6): 867–882.CrossRefPubMed
21.
Zurück zum Zitat Laskin, D.L., and K.J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annual Review of Pharmacology and Toxicology 35: 655–677.CrossRefPubMed Laskin, D.L., and K.J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annual Review of Pharmacology and Toxicology 35: 655–677.CrossRefPubMed
22.
23.
Zurück zum Zitat Fujiwara, N., and K. Kobayashi. 2005. Macrophages in inflammation. Current Drug Targets Inflammation and Allergy 4 (3): 281–286.CrossRefPubMed Fujiwara, N., and K. Kobayashi. 2005. Macrophages in inflammation. Current Drug Targets Inflammation and Allergy 4 (3): 281–286.CrossRefPubMed
24.
Zurück zum Zitat Jin, M., T.C. Moon, Z. Quan, E. Lee, Y.K. Kim, J.H. Yang, S.J. Suh, et al. 2008. The naturally occurring flavolignan, deoxypodophyllotoxin, inhibits lipopolysaccharide-induced iNOS expression through the NF-kappaB activation in RAW264.7 macrophage cells. Biological & Pharmaceutical Bulletin 31 (7): 1312–1315.CrossRef Jin, M., T.C. Moon, Z. Quan, E. Lee, Y.K. Kim, J.H. Yang, S.J. Suh, et al. 2008. The naturally occurring flavolignan, deoxypodophyllotoxin, inhibits lipopolysaccharide-induced iNOS expression through the NF-kappaB activation in RAW264.7 macrophage cells. Biological & Pharmaceutical Bulletin 31 (7): 1312–1315.CrossRef
25.
Zurück zum Zitat Leon, C.G., R. Tory, J. Jia, O. Sivak, and K.M. Wasan. 2008. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharmaceutical Research 25 (8): 1751–1761.CrossRefPubMedPubMedCentral Leon, C.G., R. Tory, J. Jia, O. Sivak, and K.M. Wasan. 2008. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharmaceutical Research 25 (8): 1751–1761.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Brubaker, A.L., J.L. Palmer, and E.J. Kovacs. 2011. Age-related Dysregulation of Inflammation and Innate Immunity: Lessons Learned from Rodent Models. Aging and Disease 2 (5): 346–360.PubMedPubMedCentral Brubaker, A.L., J.L. Palmer, and E.J. Kovacs. 2011. Age-related Dysregulation of Inflammation and Innate Immunity: Lessons Learned from Rodent Models. Aging and Disease 2 (5): 346–360.PubMedPubMedCentral
27.
Zurück zum Zitat Pahl, H.L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (49): 6853–6866.CrossRefPubMed Pahl, H.L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (49): 6853–6866.CrossRefPubMed
28.
Zurück zum Zitat Luo, J.L., H. Kamata, and M. Karin. 2005. IKK/NF-kappaB signaling: balancing life and death—a new approach to cancer therapy. The Journal of Clinical Investigation 115 (10): 2625–2632.CrossRefPubMedPubMedCentral Luo, J.L., H. Kamata, and M. Karin. 2005. IKK/NF-kappaB signaling: balancing life and death—a new approach to cancer therapy. The Journal of Clinical Investigation 115 (10): 2625–2632.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Mohamed, M.R., and G. McFadden. 2009. NFkB inhibitors: strategies from poxviruses. Cell Cycle 8 (19): 3125–3132.CrossRefPubMed Mohamed, M.R., and G. McFadden. 2009. NFkB inhibitors: strategies from poxviruses. Cell Cycle 8 (19): 3125–3132.CrossRefPubMed
30.
Zurück zum Zitat Arthur, J.S., and S.C. Ley. 2013. Mitogen-activated protein kinases in innate immunity. Nature Reviews Immunology 13 (9): 679–692.CrossRefPubMed Arthur, J.S., and S.C. Ley. 2013. Mitogen-activated protein kinases in innate immunity. Nature Reviews Immunology 13 (9): 679–692.CrossRefPubMed
32.
Zurück zum Zitat Turjanski, A.G., J.P. Vaque, and J.S. Gutkind. 2007. MAP kinases and the control of nuclear events. Oncogene 26 (22): 3240–3253.CrossRefPubMed Turjanski, A.G., J.P. Vaque, and J.S. Gutkind. 2007. MAP kinases and the control of nuclear events. Oncogene 26 (22): 3240–3253.CrossRefPubMed
33.
Zurück zum Zitat Jia, N., Y. Li, Y. Wu, M. Xi, G. Hur, X. Zhang, J. Cui, W. Sun, and A. Wen. 2012. Comparison of the anti-inflammatory and analgesic effects of Gentiana macrophylla Pall. and Gentiana straminea Maxim., and identification of their active constituents. Journal of Ethnopharmacology 144 (3): 638–645.CrossRefPubMed Jia, N., Y. Li, Y. Wu, M. Xi, G. Hur, X. Zhang, J. Cui, W. Sun, and A. Wen. 2012. Comparison of the anti-inflammatory and analgesic effects of Gentiana macrophylla Pall. and Gentiana straminea Maxim., and identification of their active constituents. Journal of Ethnopharmacology 144 (3): 638–645.CrossRefPubMed
Metadaten
Titel
Roburic Acid Suppresses NO and IL-6 Production via Targeting NF-κB and MAPK Pathway in RAW264.7 Cells
verfasst von
Yufen Chen
Ning Ji
Shunli Pan
Zhe Zhang
Ran Wang
Yuling Qiu
Meihua Jin
Dexin Kong
Publikationsdatum
31.07.2017
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2017
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0636-z

Weitere Artikel der Ausgabe 6/2017

Inflammation 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.